¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antigen"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigen shift
    Ç׿ø ´ëº¯ÀÌ
  • antigen unit
    Ç׿ø ´ÜÀ§
  • antigen-antibody reaction
    Ç׿ø-Ç×ü ¹ÝÀÀ
  • antigenic assay
    Ç׿ø¼º ºÐ¼®
  • antigenic specificity
    Ç׿ø ƯÀ̼º
  • antigenic suicide
    Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸ê
    °íµµ·Î ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» »ýü¿¡ Åõ¿©Çϸé ÀÌ Ç׿ø¿¡ ´ëÇÏ¿© °¨¼ö¼ºÀÌ ÀÖ´Â ¸²ÇÁ±¸´Â °¨¼Ò ³»Áö ºÒȰ¼ºÈ­µÇ¾î ¹ö¸°´Ù. µû¶ó¼­ ¹æ»ç Ȱ¼ºÀÌ ¾ø´Â °°Àº Ç׿øÀ» Åõ¿©Çصµ ÀÌ Ç׿ø¿¡ ƯÀÌÀûÀÎ ¸é¿ª ÀÀ´äÀº »ý±âÁö ¾Ê°Ô µÈ´Ù. À̰ÍÀº Ç׿ø¿¡ ¹ÝÀÀÇÏ´Â ¸²ÇÁ±¸°¡ ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» °áÇÕ½ÃÅ´À¸·Î½á ¹æ»ç´É¿¡ ÀÇÇÑ ¼¼Æ÷ ¼Õ»óÀ» ÀԾ ¾ß±âµÇ´Â °ÍÀÌ´Ù. À̰ÍÀ» Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸êÀ̶ó°í ÇÑ´Ù.
  • antigenicity
    ¹ÝÀÀ¿ø¼º, Ç׿ø¼º
    1. ¾î¶² Ç׿øÀÌ ±× ¹°Áú¿¡ ´ëÇÑ Æ¯ÀÌ ¸é¿ª ÀÀ´ä »ê¹°ÀÎ Ç×ü¿Í °áÇÕÇϰųª, °¨ÀÛµÈ T ¼¼Æ÷¿Í ¹ÝÀÀÇÏ´Â ¼ºÁúÀ» ¸»ÇÑ´Ù. 2. ¾î¶² ¹°ÁúÀ» »ýü¿¡ Åõ¿©ÇßÀ» ¶§ ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ´É·ÂÀ» Ç׿ø¼ºÀ̶ó°í ÇÑ´Ù. ¶Ç ¾î¶² ¹°ÁúÀÌ Ç×ü¿Í °áÇÕÇÏ´Â ´É·ÂÀ» ¹ÝÀÀ¿ø¼ºÀ̶ó°í ÇÑ´Ù. ¸é¿ª¿ø¼º, ¹ÝÀÀ¿ø¼ºÀÇ ¾çÂÊÀÇ ¼º°ÝÀ» Ç׿ø¼ºÀ̶ó°í ÇÑ´Ù. ÇÕÅÙ µîÀÇ ºÐÀÚ´Â ¹ÝÀÀ¿ø¼ºÀ» °¡Áö°í ÀÖÁö¸¸ ±×°Í ÀÚü¿¡´Â ¸é¿ª¿ø¼ºÀÌ ¾ø´Ù. ±×·¯³ª ¸é¿ª¿ø¼ºÀ» °¡Áö°í ÀÖ´Â ´Ü¹é ºÐÀÚ¿¡ ÇÕÅÙÀ» °áÇÕ½Ã۸é ÀÌ ´ãüÀ§ÀÇ ÇÕÅÙÀº ¸é¿ª¿ø¼ºÀ» ȹµæÇÑ´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigen recognition site
    Ç׿ø ½Äº°ºÎ
  • antigen shift
    Ç׿ø ´ëº¯ÀÌ
  • antigen unit
    Ç׿ø ´ÜÀ§
  • antigen-antibody reaction
    Ç׿ø-Ç×ü ¹ÝÀÀ
  • carcinoembryonic antigen assay
    ¾Ï ¹è¾Æ¼º Ç׿ø ÃøÁ¤, ¾Ï¼º ¹è¾Æ¼º Ç׿ø ÃøÁ¤
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü ¹éÇ÷±¸ Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü ¹éÇ÷±¸ Ç׿ø
  • dander antigen
    Àμ³ Ç׿ø
    ÇǺÎÀÇ Ç¥¸éÀ¸·ÎºÎÅÍ ²÷ÀÓ¾øÀÌ »êÆ÷µÇ°í ÀÖ´Â ¹°ÁúÀÇ È¥ÇÕ¹°. ¹Ú¸®µÈ »óÇÇ ¼¼¹Î, ÅÐÀÇ ´ÜÆí, ÇǺÎÀÇ Áö¹æ µîÀÌ Æ÷ÇԵǴµ¥ ƯÈ÷ Àμ³ÀÌ Áß¿äÇÏ´Ù. ¾ÆÅäÇǰ¡ ÀÖ´Â »ç¶÷¿¡¼­´Â Áï½ÃÇü °ú¹ÎÁõÀÇ ¿øÀÎÀÌ µÇ´Â ¼ö°¡ ÀÖ´Ù.
  • determinant antigen
    Ç׿ø °áÁ¤±º, °áÁ¤ Ç׿ø
    ¸é¿ªÇÐÀû ƯÀ̼ºÀ» °áÁ¤Çϴ ƯÁ¤ÀÇ È­ÇÐÀûÀÎ ºÐÀÚ±º.
  • diego antigen
    µð¿¡°í Ç׿ø
  • differentiation antigen
    ºÐÈ­ Ç׿ø
    ¼¼Æ÷°¡ ºÐÈ­ÇØ °¡´Âµ¥ À־ Ç¥ÇöµÇ´Â ¼¼Æ÷¸· »óÀÇ Ç׿ø. T ¼¼Æ÷¿¡¼­´Â B ¼¼Æ÷·ÎºÎÅÍ ±¸º°ÇÏ´Â ºÐÈ­ Ç׿øÀº mouse »çÀÌ¿¡¼­ ¼¼Æ÷¸¦ Åõ¿©ÇÏ¿© ¸¸µé¾îÁø µ¿Á¾ Ç×Ç÷û¿¡ ÀÇÇÏ¿© °ËÃâµÇ´Â Ç׿ø
  • DR antigen
    DR Ç׿ø
    HLA-D ¿µ¿ª À¯ÀüÀÚÀÇ Áö¹è¸¦ ¹Þ´Â Ç׿øÀ̸ç, ÁÖ·Î B ¼¼Æ÷ ¹× macro
  • endogenous antigen
    ³»ºÎ Ç׿ø
    µ¿¹°ÀÇ Ã¼³»¿¡ Á¸ÀçÇÏ´Â °Íµé·Î¼­ µ¿¹°ÀÇ Á¶Á÷, ¼¼Æ÷ÀÇ ÀϺΠ±¸¼º ¼ººÐ µîÀÌ ¿©±â¿¡ ¼ÓÇÑ´Ù.
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • fetal antigen
    ÅÂ¾Æ Ç׿ø
    Á¾¾ç °ü·Ã Ç׿øÀÇ ÀÏÁ¾, Å»ý±â Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö¸¸, Á¤»óÀûÀÎ ºÐÈ­¸¦ ¹âÀº Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö ¾Ê°Å³ª ±ØÈ÷ ¹Ì·® Á¸ÀçÇϰųª ÇÑ´Ù.
ÅëÇÕ°Ë»ö ¿Ï·á